Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-9605

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-9605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figr1 (Figr1)

This is a drug interaction table showing the interaction of several drugs with ethanol and their impact on different analytes, including Cmax and AUC. The drugs listed include Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. The table provides recommendations for dose adjustments, caution, or avoidance of concomitant use depending on the impact on the analytes.*

FDA Label Image

Figr2 (Figr2)

This is a drug interaction table that lists multiple drugs, their interaction with other drugs, and their impact on PK parameters like Cmax and AUC. The table also provides a recommendation based on the observed changes in PK parameters.*

FDA Label Image

Figr3 (Figr3)

This appears to be a table or chart showing recommendations for adjusting venlafaxine dosages in different populations based on PK (pharmacokinetics), fold change, and 90% CI (confidence interval). The populations include those with hepatic impairment (cirrhosis, mild impairment, moderate impairment, and mild/moderate impairment), renal impairment (hemodialysis), CYP2D6 polymorphism, age (> 60 years), and gender. The recommendations involve reducing the dose by a certain percentage or individualizing dosing based on the analyte levels, such as Cmax and AUC. The chart also includes fold change values relative to a reference value.*

FDA Label Image

Label (Lbl713359605)

This is a description of a medication called Venlafaxine ER. It is in capsule form with a strength of 37.5mg. The medication may cause drowsiness and should be stored at room temperature. The medication is packaged by Buyant Ranch Prepach Bunbank and the manufacturer is Camber Pharmaceuticals Inc. The item is sold in packs of 30 capsules and can be compared to Effexor XR 37.5. The NDC (National Drug Code) number for the item is 7133596051 04725301523487.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.